全文获取类型
收费全文 | 7719篇 |
免费 | 417篇 |
国内免费 | 56篇 |
专业分类
耳鼻咽喉 | 62篇 |
儿科学 | 158篇 |
妇产科学 | 60篇 |
基础医学 | 848篇 |
口腔科学 | 150篇 |
临床医学 | 537篇 |
内科学 | 1943篇 |
皮肤病学 | 256篇 |
神经病学 | 454篇 |
特种医学 | 271篇 |
外科学 | 1657篇 |
综合类 | 40篇 |
预防医学 | 199篇 |
眼科学 | 102篇 |
药学 | 483篇 |
中国医学 | 14篇 |
肿瘤学 | 958篇 |
出版年
2023年 | 73篇 |
2022年 | 112篇 |
2021年 | 274篇 |
2020年 | 145篇 |
2019年 | 171篇 |
2018年 | 257篇 |
2017年 | 205篇 |
2016年 | 232篇 |
2015年 | 231篇 |
2014年 | 244篇 |
2013年 | 310篇 |
2012年 | 482篇 |
2011年 | 564篇 |
2010年 | 314篇 |
2009年 | 241篇 |
2008年 | 362篇 |
2007年 | 428篇 |
2006年 | 399篇 |
2005年 | 369篇 |
2004年 | 393篇 |
2003年 | 396篇 |
2002年 | 355篇 |
2001年 | 123篇 |
2000年 | 105篇 |
1999年 | 98篇 |
1998年 | 75篇 |
1997年 | 57篇 |
1996年 | 57篇 |
1995年 | 59篇 |
1994年 | 48篇 |
1993年 | 44篇 |
1992年 | 59篇 |
1991年 | 66篇 |
1990年 | 47篇 |
1989年 | 66篇 |
1988年 | 62篇 |
1987年 | 59篇 |
1986年 | 37篇 |
1985年 | 47篇 |
1984年 | 50篇 |
1983年 | 52篇 |
1982年 | 22篇 |
1979年 | 34篇 |
1977年 | 24篇 |
1975年 | 26篇 |
1972年 | 40篇 |
1971年 | 31篇 |
1970年 | 31篇 |
1969年 | 33篇 |
1968年 | 27篇 |
排序方式: 共有8192条查询结果,搜索用时 15 毫秒
91.
Green tea component, catechin, induces apoptosis of human malignant B cells via production of reactive oxygen species. 总被引:5,自引:0,他引:5
Tomonori Nakazato Keisuke Ito Yasuo Ikeda Masahiro Kizaki 《Clinical cancer research》2005,11(16):6040-6049
PURPOSE: Green tea polyphenol, (-)-epigallocatechin-3-gallate, has been shown to inhibit cellular proliferation and induce apoptosis of various cancer cells. The aim of this study was to investigate the possibility of (-)-epigallocatechin-3-gallate as a novel therapeutic agent for the patients with B-cell malignancies including multiple myeloma. EXPERIMENTAL DESIGN: We investigated the effects of (-)-epigallocatechin-3-gallate on the induction of apoptosis in HS-sultan as well as myeloma cells in vitro and further examined the molecular mechanisms of (-)-epigallocatechin-3-gallate-induced apoptosis. RESULTS: (-)-Epigallocatechin-3-gallate rapidly induced apoptotic cell death in various malignant B-cell lines in a dose- and time-dependent manner. (-)-Epigallocatechin-3-gallate-induced apoptosis was in association with the loss of mitochondrial transmembrane potentials (Deltapsim); the release of cytochrome c, Smac/DIABLO, and AIF from mitochondria into the cytosol; and the activation of caspase-3 and caspase-9. Elevation of intracellular reactive oxygen species (ROS) production was also shown during (-)-epigallocatechin-3-gallate-induced apoptosis of HS-sultan and RPMI8226 cells as well as fresh myeloma cells. Antioxidant, catalase, and Mn superoxide dismutase significantly reduced ROS production and (-)-epigallocatechin-3-gallate-induced apoptosis, suggesting that ROS plays a key role in (-)-epigallocatechin-3-gallate-induced apoptosis in B cells. Furthermore, a combination with arsenic trioxide (As2O3) and (-)-epigallocatechin-3-gallate significantly enhanced induction of apoptosis compared with As2O3 alone via decreased intracellular reduced glutathione levels and increased production of ROS. CONCLUSIONS: (-)-Epigallocatechin-3-gallate has potential as a novel therapeutic agent for patients with B-cell malignancies including multiple myeloma via induction of apoptosis mediated by modification of the redox system. In addition, (-)-epigallocatechin-3-gallate enhanced As2O3-induced apoptosis in human multiple myeloma cells. 相似文献
92.
T Ueha-Ishibashi T Tatsuishi K Iwase H Nakao C Umebayashi Y Nishizaki Y Nishimura Y Oyama S Hirama Y Okano 《Toxicology in vitro》2004,18(5):563-569
There is a concern on the part of public health community that adverse health consequences by thimerosal, a preservative in vaccines for infants, may occur among infants during immunization schedule. Therefore, the effect of thimerosal on cellular content of glutathione was examined on thymocytes obtained from 4-week-old rats using a flow cytometer and 5-chloromethylfluorescein diacetate. Thimerosal at concentrations ranging from 1 to 10 microM reduced the cellular content of glutathione in a concentration-dependent manner, and the complete depletion of cellular glutathione was observed when the cells were treated with 30 microM thimerosal. L-Cysteine significantly attenuated the actions of thimerosal to reduce the glutathione content and to increase the intracellular Ca2+ concentration. Prolonged incubation (24 h) with 1-3 microM thimerosal induced the apoptosis. The cytotoxic action of thimerosal was greatly augmented when the cells suffered oxidative stress induced by H2O2. It may be unlikely that thimerosal exerts potent cytotoxic action under the in vivo condition because the blood concentration of thimerosal after receiving vaccines does not seem to reach micromolar range and nonprotein thiols at micromolar concentrations are present in the blood. 相似文献
93.
94.
Masahiko Yamamoto Kazuo Ishikawa Mitsuhiro Aoki Keisuke Mizuta Yatsuji Ito Masatsugu Asai Hideo Shojaku Toshiaki Yamanaka Chisato Fujimoto Toshihisa Murofushi Tomoe Yoshida 《Auris, nasus, larynx》2018,45(2):201-206
Stabilometry is a useful tool for examining patients with functional disorders of the vestibular system. However, measurement techniques and devices vary by country. Therefore, international standardization of stabilometry is mandatory to validate the exchange of important findings. This was advocated at the 1983 Posturography Meeting in Kyoto but has not been adopted worldwide, and each country has continued to use unique regional measurement methods. In Japan, stabilometry has widespread application in medical practice in conjunction with research into its applications. With a goal of international standardization, we present details of stabilometry measurement methods and their application in Japan, together with a brief history and potential future directions of stabilometry. 相似文献
95.
96.
Tomohisa Furuya Satoru Sugimoto Chie Kurokawa Shuichi Ozawa Kumiko Karasawa Keisuke Sasai 《Journal of radiation research》2013,54(1):157-165
To evaluate the dosimetric impact of respiratory breast motion and daily setup error on whole breast irradiation (WBI) using three irradiation techniques; conventional wedge (CW), field-in-field (FIF) and irregular surface compensator (ISC). WBI was planned for 16 breast cancer patients. The dose indices for evaluated clinical target volume (CTVevl), lung, and body were evaluated. For the anterior-posterior (AP) respiratory motion and setup error of a single fraction, the isocenter was moved according to a sine function, and the dose indices were averaged over one period. Furthermore, the dose indices were weighted according to setup error frequencies that have a normal distribution to model systematic and random setup error for the entire treatment course. In all irradiation techniques, AP movement has a significant impact on dose distribution. CTVevlD95 (the minimum relative dose that covers 95 % volume) and V95 (the relative volume receiving 95 % of the prescribed dose) were observed to significantly decrease from the original ISC plan when simulated for the entire treatment course. In contrast, the D95, V95 and dose homogeneity index did not significantly differ from those of the original plans for FIF and CW. With regard to lung dose, the effect of motion was very similar among all three techniques. The dosimetric impact of AP respiratory breast motion and setup error was largest for the ISC technique, and the second greatest effect was observed with the FIF technique. However, these variations are relatively small. 相似文献
97.
Aki Masuzawa Chikako Kiyotani Tomoo Osumi Yoko Shioda Kazutoshi Iijima Osamu Tomita Kazuhiko Nakabayashi Keisuke Oboki Kazuki Yasuda Hiromi Sakamoto Hitoshi Ichikawa Kenichiro Hata Teruhiko Yoshida Kenji Matsumoto Nobutaka Kiyokawa Tetsuya Mori 《European journal of haematology》2014,92(3):263-267
In addition to BCR, various rare fusion partners for the ABL1 gene have been reported in leukemia. We have identified the fusion gene SNX2‐ABL1 in a pediatric case of acute lymphoblastic leukemia (ALL), which has only once previously been reported in an adult patient. Cytogenetic analysis detected this fusion gene arising from a t(5;9)(q22;q34) translocation. ALL cells carrying a SNX2‐ABL1 fusion exhibited a BCR‐ABL1+ ALL‐like gene expression profile. The patient poorly responded to dasatinib but partially responded to imatinib. Treatment using tyrosine kinase inhibitors requires further investigation to optimize the genotype‐based treatment stratification for patients with SNX2‐ABL1 fusion. 相似文献
98.
99.